Marjolijn Berghmans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marjolijn Berghmans has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Babette Deckers
VIB-VUB Center for Structural Biology, Brussels, Belgium
1 shared publication - Christian Galicia
Structural Biology Brussels, Vrije Universiteit Brussel
1 shared publication - Ella Martin
Structural Biology Brussels, Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050
1 shared publication - Els Pardon
VIB-VUB center for Structural Biology, VIB, pleinlaan 2, 1050 Brussels, Belgium
1 shared publication - Jan Steyaert
VIB-VUB center for Structural Biology, VIB, pleinlaan 2, 1050 Brussels, Belgium
1 shared publication - Jone Paesmans
VIB-VUB Center for Structural Biology, Brussels, Belgium
1 shared publication
Latest Publications
- Open Access
- 22 December 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
A structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
Synaptojanin1 (Synj1) is a phosphoinositide phosphatase, important in clathrin uncoating during endocytosis of presynaptic vesicles. It was identified as a potential drug target for Alzheimer’s disease, Down syndrome, and TBC1D24-associated epilepsy, while also loss-of-function mutations in Synj1 are associated with epilepsy and Parkinson’s disease. Despite its involvement in a range of disorders, structural, and detailed mechanistic information regarding the enzyme is lacking. Here, we report the crystal structure of the 5-phosphatase domain of Synj1. Moreover, we also present a structure of this domain bound to the substrate diC8-PI(3,4,5)P3, providing the first image of a 5-phosphatase with a trapped substrate in its active site. Together with an analysis of the contribution of the different inositide phosphate groups to catalysis, these structures provide new insights in the Synj1 mechanism. Finally, we analysed the effect of three clinical missense mutations (Y793C, R800C, Y849C) on catalysis, unveiling the molecular mechanisms underlying Synj1-associated disease.
- 22 December 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessA structure of substrate-bound Synaptojanin1 provides new insights in its mechanism and the effect of disease mutations
Synaptojanin1 (Synj1) is a phosphoinositide phosphatase, important in clathrin uncoating during endocytosis of presynaptic vesicles. It was identified as a potential drug target for Alzheimer’s disease, Down syndrome, and TBC1D24-associated epilepsy, while also loss-of-function mutations in Synj1 are associated with epilepsy and Parkinson’s disease. Despite its involvement in a range of disorders, structural, and detailed mechanistic information regarding the enzyme is lacking. Here, we report the crystal structure of the 5-phosphatase domain of Synj1. Moreover, we also present a structure of this domain bound to the substrate diC8-PI(3,4,5)P3, providing the first image of a 5-phosphatase with a trapped substrate in its active site. Together with an analysis of the contribution of the different inositide phosphate groups to catalysis, these structures provide new insights in the Synj1 mechanism. Finally, we analysed the effect of three clinical missense mutations (Y793C, R800C, Y849C) on catalysis, unveiling the molecular mechanisms underlying Synj1-associated disease.